A recent study looked at how cannabis can help those previously diagnosed with hepatitis C avoid risk of diabetes. It revealed that those who use cannabis are less likely to develop diabetes as a result of the hepatitis C.
Articles
Psychedelic Drugs Go Mainstream
As the Renaissance for psychedelic drugs progresses, we see these substances acquiring mainstream status in various ways.
Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
Champignon Brands advises that the BCSC has revoked its original cease trade order (June 19, 2020), but a replacement order remains in effect.
Medical Marijuana Patients In Florida Can Now Access Edibles
It’s been four years since Florida voters signed off on a law legalizing medical marijuana, but cannabis patients in the Sunshine State have been unable to receive treatment in the form of edibles—until now.
Study Finds Medical Cannabis Improves Seniors’ Quality Of Life
A new study from researchers affiliated with two midwestern universities has found that the medicinal use of cannabis improves the quality of life of seniors.
Most Legal Marijuana States Had Fewer Vaping-Related Lung Injuries, Study Finds
States that have enacted marijuana legalization were generally less likely to see spikes in vaping-related lung injuries that occurred over the past year compared to states where cannabis remains prohibited, according to a new study.
Pennsylvania Gov. Demands State Legalize Marijuana To Boost Economy
Add Pennsylvania Gov. Tom Wolf to the growing body of state lawmakers proposing cannabis legalization as a way to boost local funding and economies.
Legalizing Medical Marijuana Could Free Up Federal Medicaid Dollars, American Samoa Official Says
Officials in American Samoa are considering legalizing medical marijuana to generate funds for a government health care program in the U.S. territory.
Mydecine Innovations Group Announces Extended Lock-Up Arrangement
Certain large Mydecine shareholders have entered into a voluntary lock-up, covering 52,908,420 common shares.
Study Shows Cannabis Could Help People Quit IV Opiate Use
Recent data published in the American Journal of Public Health shows that those who use cannabis are more likely to be able to quit injectable opioids.
Curaleaf rises to the top of US marijuana industry with footprint covering about two dozen states
Massachusetts-based Curaleaf has become one of the largest multistate cannabis operators in the United States by adopting a broad-market approach – with scores of cultivation, processing and dispensary facilities now stretching across 23 states.
MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD
MindMed is utilizing MDMA with LSD, to endeavour to reduce side effects of LSD-assisted therapy.
Virginia’s Special Legislative Sessions Considers More Macro and Micro Cannabis Reforms
The special legislative session convened by Virginia Governor Ralph Northam began last week on Tuesday August 18, and among the issues discussed are ongoing changes both big and small to cannabis reform in the state.
Why Are Silicon Valley AND Wall Street Backing Psychedelic Drugs?
Wall Street and Silicon Valley investors recently piled into a $30-million psychedelics fund-raising initiative.
Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation
Field Trip Psychedelics completes its qualifying transaction and definitive agreement with RTO partner.